Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00159107
Status:
COMPLETED
Last Update Posted:
2008-01-30
First Post:
2005-09-07
Brief Title:
Integrative Therapy in Alcoholism
Sponsor:
Heinrich-Heine University Duesseldorf
Organization:
Heinrich-Heine University Duesseldorf
Study Overview
Official Title:
Acamprosate and Integrative Behavior Therapy in the Outpatient Treatment of Alcohol Dependents
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main aim of this project consists in the investigation of the interaction of behavior therapy and Acamprosate in the outpatient treatment of alcoholic patients in a randomized prospective and regarding study medication Acamprosate vs Placebo double blind design A total of 371 patients has been randomly assigned immediately after detoxification to one of three different outpatient treat-ment conditions
Detailed Description:
The objective of this multi-center study is to optimize the long-term treatment of patients with alcohol dependence This investigation should contribute to the issue of effective relapse prevention Each treatment condition is lasting 6 months a Behavior Group Therapy Acamprosate b Behavior Group Therapy Placebo and c support and counseling Acamprosate Follow-up examinations carried out 3 and 6 months after the end of treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None